Agency
Southern Nevada Health District
Southern Nevada Health District was paid $6.06M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is J0561, Injection, penicillin g benzathine, 100,000 units — 14% of everything it billed.
33Billing provider infoSOUTHERN NEVADA HEALTH DISTRICT
LAS VEGAS, NV 89107
LAS VEGAS, NV 89107
33aNPI1275550212assigned 07/16/2006
33bProvider typePublic Health or Welfare Agency
28Total paid$6.06M
24GClaims308,878
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Public Health or Welfare Agency providers in Nevada
Rank by total paid#1 of 8
Median peer was paid$624.00
This provider vs. median9,715×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 51,626 | $497K | |
| 2019 | 54,925 | $566K | |
| 2020 | 27,982 | $397K | |
| 2021 | 33,605 | $613K | |
| 2022 | 34,013 | $831K | |
| 2023 | 64,042 | $1.70M | |
| 2024incomplete | 42,685 | $1.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0561 | Injection, penicillin g benzathine, 100,000 units | 14% | 4,117 | 2,517 | $852K |
| 90716 | 14% | 13,187 | 12,945 | $832K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 11% | 44,688 | 42,369 | $683K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 9.6% | 63,826 | 61,520 | $579K |
| 90746 | 8.5% | 10,093 | 9,850 | $512K | |
| 90707 | 7.5% | 11,848 | 11,583 | $455K | |
| 90651 | 6.6% | 13,084 | 12,839 | $397K | |
| 90715 | 4.9% | 20,049 | 19,519 | $299K | |
| 91320 | 2.9% | 2,683 | 2,494 | $175K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.3% | 4,239 | 3,689 | $138K |
| 90674 | 1.9% | 7,279 | 6,976 | $116K | |
| 90480 | 1.8% | 3,533 | 3,333 | $108K |
80 more codes
| 99213 | Doctor's office visit, returning patient (routine) | 1.8% | 2,961 | $106K |
| 90620 | 1.5% | 4,423 | $91K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.4% | 7,552 | $86K |
| 90632 | 1.3% | 1,769 | $78K | |
| 90636 | <1% | 895 | $58K | |
| 90734 | <1% | 10,852 | $44K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,695 | $39K |
| 0124A | <1% | 1,009 | $37K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 704 | $36K |
| 90619 | <1% | 3,241 | $26K | |
| 91322 | <1% | 299 | $26K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,434 | $25K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,477 | $25K |
| 90756 | <1% | 1,141 | $21K | |
| 90750 | <1% | 194 | $19K | |
| 90661 | <1% | 1,109 | $19K | |
| 90713 | <1% | 5,709 | $17K | |
| 90688 | <1% | 1,820 | $17K | |
| 90739 | <1% | 2,365 | $16K | |
| 0121A | <1% | 562 | $15K | |
| 90710 | <1% | 7,092 | $13K | |
| 90670 | <1% | 2,700 | $12K | |
| 0051A | <1% | 336 | $11K | |
| 0052A | <1% | 283 | $11K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 177 | $10K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 16 | $10K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 96 | $7K |
| 81025 | <1% | 1,783 | $6K | |
| 90714 | <1% | 619 | $5K | |
| 90686 | <1% | 5,769 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 322 | $3K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 15 | $2K |
| 90677 | <1% | 80 | $2K | |
| 90744 | <1% | 3,263 | $2K | |
| 99070 | <1% | 290 | $2K | |
| 99384 | <1% | 21 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 108 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 137 | $1K |
| 90697 | <1% | 135 | $1K | |
| 0054A | <1% | 34 | $1K | |
| 0134A | <1% | 36 | $920.00 | |
| 90691 | <1% | 14 | $768.34 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 513 | $700.95 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 16 | $667.33 |
| 87808 | <1% | 209 | $664.23 | |
| 86780 | <1% | 104 | $623.07 | |
| 87905 | <1% | 180 | $582.23 | |
| 90656 | <1% | 42 | $574.29 | |
| 69210 | <1% | 15 | $498.31 | |
| 91319 | <1% | 219 | $323.08 | |
| 86703 | <1% | 42 | $253.17 | |
| 90653 | <1% | 30 | $251.53 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 104 | $250.50 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 60 | $187.50 |
| 83655 | <1% | 30 | $177.66 | |
| 90648 | <1% | 1,228 | $161.37 | |
| 91318 | <1% | 49 | $160.00 | |
| 90633 | <1% | 9,273 | $129.11 | |
| 36416 | <1% | 53 | $59.80 | |
| 83986 | <1% | 46 | $48.55 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 374 | $43.11 |
| A4267 | Contraceptive supply, condom, male, each | <1% | 359 | $31.84 |
| G0008 | Administration of influenza virus vaccine | <1% | 116 | $20.00 |
| 90696 | <1% | 2,514 | $7.80 | |
| 91312 | <1% | 1,540 | $7.08 | |
| 91305 | <1% | 544 | $3.48 | |
| 91313 | <1% | 31 | $0.18 | |
| 91315 | <1% | 29 | $0.13 | |
| 90698 | 0% | 743 | $0.00 | |
| 90723 | 0% | 1,591 | $0.00 | |
| 99000 | 0% | 1,241 | $0.00 | |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | 0% | 328 | $0.00 |
| 90694 | 0% | 18 | $0.00 | |
| 90700 | 0% | 3,647 | $0.00 | |
| 91321 | 0% | 52 | $0.00 | |
| 90681 | 0% | 212 | $0.00 | |
| S0197 | Prenatal vitamins, 30-day supply | 0% | 17 | $0.00 |
| 90685 | 0% | 106 | $0.00 | |
| 99173 | 0% | 24 | $0.00 | |
| 90662 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOCKETT, CASSIUS (DISTRICT HEALTH OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Southern Nevada Health District | Las Vegas, NV | $273K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.